Texas Permanent School Fund Abbott Laboratories Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $7.11 Million - $7.94 Million	-70,612 Reduced 19.68%	288,269 $30 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $61,550 - $67,979	562 Added 0.16%	358,881 $40.8 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $24,261 - $29,697	-269 Reduced 0.08%	358,319 $39.4 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $580,344 - $696,316	-6,075 Reduced 1.67%	358,588 $34.7 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $116,703 - $130,031	1,158 Added 0.32%	364,663 $39.8 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $11.2 Million - $13.2 Million	115,778 Added 46.74%	363,505 $36.8 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $5,608 - $6,579	-59 Reduced 0.02%	247,727 $27.2 Million
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $1.6 Million - $1.85 Million	16,512 Added 7.14%	247,786 $24 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $195,259 - $236,006	1,913 Added 0.83%	231,274 $25.1 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $1.62 Million - $1.97 Million	-14,183 Reduced 5.82%	229,361 $27.1 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $3.5 Million - $4.29 Million	-30,325 Reduced 11.07%	243,544 $34.3 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $2.49 Million - $2.75 Million	-21,317 Reduced 7.22%	273,869 $32.4 Million
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $66,753 - $78,578	-631 Reduced 0.21%	295,186 $34.2 Million
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $1.82 Million - $2.14 Million	-16,680 Reduced 5.34%	295,817 $35.5 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $2.14 Million - $2.33 Million	-20,371 Reduced 6.12%	312,497 $34.2 Million
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $1.94 Million - $2.36 Million	21,169 Added 6.79%	332,868 $36.2 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $745,408 - $954,030	-9,735 Reduced 3.03%	311,699 $28.5 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $546,094 - $798,538	8,693 Added 2.78%	321,434 $25.4 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $1.29 Million - $1.44 Million	-16,484 Reduced 5.01%	312,741 $27.2 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $900,485 - $976,406	-11,003 Reduced 3.23%	329,225 $27.5 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $106,331 - $124,015	-1,459 Reduced 0.43%	340,228 $28.6 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $766,893 - $927,174	-11,581 Reduced 3.28%	341,687 $27.3 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $2.66 Million - $3.01 Million	-40,560 Reduced 10.3%	353,268 $25.6 Million
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $2.07 Million - $2.49 Million	-33,997 Reduced 7.95%	393,828 $28.9 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $1.26 Million - $1.39 Million	-21,915 Reduced 4.87%	427,825 $26.1 Million
Q1 2018 Apr 20, 2018	SELL	$56.27 - $63.62 $1.43 Million - $1.62 Million	-25,432 Reduced 5.35%	449,740 $26.9 Million
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $339,848 - $363,842	-6,331 Reduced 1.31%	475,172 $27.1 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $23.1 Million - $25.8 Million	481,503	481,503 $25.7 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account